Home > Offer to Sell > Pharmaceuticals and Biochemicals > Cardiovascular agents > Dobutamine Hydrochloride Injection 49745-95-1

Dobutamine Hydrochloride Injection 49745-95-1

Inquiry
  Post Date: Nov 05,2024
  Expiry Date: May 04,2025
  Detailed Description: Cas No. :49745-95-1

It is a derivative of dopamine with prominent beta one receptor activity and negligible chronotropic and peripheral vascular activity.

Composition : 250mg/5 ml
Indications : Refractory chronic congestive heart failure not responding to digoxin. For inotropic support in bacteremic shock.
Contraindications : Acute myocardial infarction.
Safety Profile : Thrombocytopenia, platelet dysfunction, uncontrolled hypertension, diabetic retinopathy, and pregnancy
Adverse Effects : Increase in HR, BP.
Drug Interactions : Nitroprusside.
Dosage :2.5 to 10 mcg/kg in 5% dextrose by slow iv infusion.
Purity :Not less than 99%.

  CAS Registry Number:

49745-95-1
  Synonyms: ;Dobutamine Hydrochloride;4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol hydrochloride (1:1);benzene-1,2-diol hydrochloride;
  Molecular Formula: C6H7ClO2
  Molecular Weight: 146.5716
  Molecular Structure: 49745-95-1 Dobutamine HCL
  Hazard Symbols:  Xn:Harmful;
  Risk Codes: R20/21/22:;
R63:;
  Safety Description: S22:;
S26:;
S36/37/39:;

  Company: Shanghai DND Pharm-Technology Co., Inc.     [ China ]          
  Contact: Arron Yu
  Tel: 021-58783620
  Fax: 021-58783595
  Email: sales@dndpharm.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.